Ag retailers almost universally plan to increase or maintain their use of biological products in the next year, according to information presented at the BioAg World Congress. That being said, surveys indicate one of the biggest barriers to adoption is a lack of trust in product performance. With less regulation and standardization than synthetic chemistries, biological products and companies have proliferated.
“I want customers to have a healthy dose of skepticism. I want them to hold our industry to a high standard. It’s a bar we are prepared to meet and exceed at Novozymes BioAg,”
says Jason Ward, director of commercial operations in North America.
“Novozymes invests heavily in lab, greenhouse, replicated and commercial trials to prove the performance of our products. We also participate in commercial testing programs, including WinField Answer Plot®. We do this to separate ourselves from the noise in the marketplace and give growers confidence.”
Novozymes has been working with nature’s problem solvers for more than 70 years and is the global leader in microbial and enzymatic solutions. Its scientists deliver new biosolutions to a broad range of industries including crops, biofuels, animal health, home and consumer products.
Novozymes BioAg invests 13% of its revenue in research and development and has a team of 120 researchers dedicated to ag biological research for crop production.
The company’s research is focused on bioyield and biocontrol technologies for crops. Bioyield products enhance plant nutrition and stimulate plant growth. Biocontrol products supplement, enhance or replace chemical pesticides that protect crops from insects and disease. Novozymes BioAg seeks bioinnovations that improve agricultural productivity and efficiency while preserving the planet’s resources.